Literature DB >> 24325319

The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation.

Xiaolei Ding1, Xiaoying Wang, Stephanie Sontag, Jie Qin, Paul Wanek, Qiong Lin, Martin Zenke.   

Abstract

Reprogramming of somatic cells toward pluripotency involves extensive chromatin reorganization and changes in gene expression. Polycomb group (PcG) proteins are key regulators of chromatin structure, cell identity, and development. In this study, we investigated the impact of Ezh2, a core subunit of Polycomb repressive complex 2 (PRC2), on the generation of induced pluripotent stem (iPS) cells. We found that Ezh2 expression is induced during iPS cell generation and iPS cells contain high levels of Ezh2 mRNA and protein. Importantly, shRNA knockdown of Ezh2 during reprogramming severely impairs iPS cell generation. Mechanistically, Ezh2 acts during reprogramming at least in part through repressing the Ink4a/Arf locus, which represents a major roadblock for iPS cell generation. Interestingly, knockdown of Ezh2 in established pluripotent cells leaves pluripotency and self-renewal of embryonic stem cells and iPS cells unaffected. Altogether, our results demonstrate that Ezh2 is critical for efficient iPS cell generation, whereas it is dispensable for maintaining the reprogrammed iPS cell state.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24325319      PMCID: PMC3996971          DOI: 10.1089/scd.2013.0267

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  51 in total

1.  Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells.

Authors:  Xiaolei Ding; Qiong Lin; Roberto Ensenat-Waser; Stefan Rose-John; Martin Zenke
Journal:  Stem Cells Dev       Date:  2011-06-17       Impact factor: 3.272

Review 2.  Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective.

Authors:  Gaoyang Liang; Yi Zhang
Journal:  Cell Res       Date:  2012-12-18       Impact factor: 25.617

Review 3.  Molecular roadblocks for cellular reprogramming.

Authors:  Thomas Vierbuchen; Marius Wernig
Journal:  Mol Cell       Date:  2012-09-28       Impact factor: 17.970

4.  Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells.

Authors:  Francesco Neri; Alessio Zippo; Anna Krepelova; Alessandro Cherubini; Marina Rocchigiani; Salvatore Oliviero
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

5.  The polycomb-group gene Ezh2 is required for early mouse development.

Authors:  D O'Carroll; S Erhardt; M Pagani; S C Barton; M A Surani; T Jenuwein
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase.

Authors:  Yosef Buganim; Dina A Faddah; Albert W Cheng; Elena Itskovich; Styliani Markoulaki; Kibibi Ganz; Sandy L Klemm; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

7.  Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency.

Authors:  Jenny Hansson; Mahmoud Reza Rafiee; Sonja Reiland; Jose M Polo; Julian Gehring; Satoshi Okawa; Wolfgang Huber; Konrad Hochedlinger; Jeroen Krijgsveld
Journal:  Cell Rep       Date:  2012-12-27       Impact factor: 9.423

8.  A molecular roadmap of reprogramming somatic cells into iPS cells.

Authors:  Jose M Polo; Endre Anderssen; Ryan M Walsh; Benjamin A Schwarz; Christian M Nefzger; Sue Mei Lim; Marti Borkent; Effie Apostolou; Sara Alaei; Jennifer Cloutier; Ori Bar-Nur; Sihem Cheloufi; Matthias Stadtfeld; Maria Eugenia Figueroa; Daisy Robinton; Sridaran Natesan; Ari Melnick; Jinfang Zhu; Sridhar Ramaswamy; Konrad Hochedlinger
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

9.  Pluripotent stem cells escape from senescence-associated DNA methylation changes.

Authors:  Carmen M Koch; Kristina Reck; Kaifeng Shao; Qiong Lin; Sylvia Joussen; Patrick Ziegler; Gudrun Walenda; Wolf Drescher; Bertram Opalka; Tobias May; Tim Brümmendorf; Martin Zenke; Tomo Saric; Wolfgang Wagner
Journal:  Genome Res       Date:  2012-10-18       Impact factor: 9.043

10.  Cell reprogramming requires silencing of a core subset of polycomb targets.

Authors:  Giulia Fragola; Pierre-Luc Germain; Pasquale Laise; Alessandro Cuomo; Alessandro Blasimme; Fridolin Gross; Elena Signaroldi; Gabriele Bucci; Cesar Sommer; Giancarlo Pruneri; Giovanni Mazzarol; Tiziana Bonaldi; Gustavo Mostoslavsky; Stefano Casola; Giuseppe Testa
Journal:  PLoS Genet       Date:  2013-02-28       Impact factor: 5.917

View more
  21 in total

1.  Competition between PRC2.1 and 2.2 subcomplexes regulates PRC2 chromatin occupancy in human stem cells.

Authors:  Daniel T Youmans; Anne R Gooding; Robin D Dowell; Thomas R Cech
Journal:  Mol Cell       Date:  2020-12-17       Impact factor: 17.970

Review 2.  Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.

Authors:  Mark van den Hurk; Gunter Kenis; Cedric Bardy; Daniel L van den Hove; Fred H Gage; Harry W Steinbusch; Bart P Rutten
Journal:  Epigenomics       Date:  2016-07-15       Impact factor: 4.778

3.  Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.

Authors:  Sophie Dal-Pra; Conrad P Hodgkinson; Maria Mirotsou; Imke Kirste; Victor J Dzau
Journal:  Circ Res       Date:  2017-02-16       Impact factor: 17.367

Review 4.  DNA methylation and hydroxymethylation in stem cells.

Authors:  Ying Cheng; Nina Xie; Peng Jin; Tao Wang
Journal:  Cell Biochem Funct       Date:  2015-03-16       Impact factor: 3.685

5.  An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage.

Authors:  Gamze Kuser-Abali; Lu Gong; Jiawei Yan; Qingqing Liu; Weiqi Zeng; Amanda Williamson; Chuan Bian Lim; Mary Ellen Molloy; John B Little; Lei Huang; Zhi-Min Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-14       Impact factor: 11.205

Review 6.  Current status in cancer cell reprogramming and its clinical implications.

Authors:  Kenan Izgi; Halit Canatan; Banu Iskender
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

Review 7.  Cancer: pathological nuclear reprogramming?

Authors:  Colin R Goding; Duanqing Pei; Xin Lu
Journal:  Nat Rev Cancer       Date:  2014-07-17       Impact factor: 60.716

Review 8.  A decade of transcription factor-mediated reprogramming to pluripotency.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-17       Impact factor: 94.444

Review 9.  Epigenetic mechanisms of induced pluripotency.

Authors:  Marta Gładych; Anastazja Andrzejewska; Urszula Oleksiewicz; Marcos R H Estécio
Journal:  Contemp Oncol (Pozn)       Date:  2015

10.  Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming.

Authors:  Calley L Hirsch; Zeynep Coban Akdemir; Li Wang; Gowtham Jayakumaran; Dan Trcka; Alexander Weiss; J Javier Hernandez; Qun Pan; Hong Han; Xueping Xu; Zheng Xia; Andrew P Salinger; Marenda Wilson; Frederick Vizeacoumar; Alessandro Datti; Wei Li; Austin J Cooney; Michelle C Barton; Benjamin J Blencowe; Jeffrey L Wrana; Sharon Y R Dent
Journal:  Genes Dev       Date:  2015-04-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.